Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Plexus Corp.

PLXSNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 13, 2026Accepted Aug 13, 2026, 4:16 PM EDTFiling CIK 785786Accession 0001189053-26-000009
Share

Structured filing — 4

wk-form4_1786652192.xml

Open full document ↗

Filing details

Report period
2026-08-11
Issuer
PLEXUS CORP
Issuer CIK
0000785786
Trading symbol
PLXS
Rule 10b5-1 indication
Checked

Reporting owner 1

Name
SCHROCK MICHAEL V
Reporting owner CIK
0001189053
Relationship
Director
Address
ONE PLEXUS WAY, NEENAH, WI, 54956

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock, $.01 par value2026-08-11S · Form 4[F1]4,000D27540,329D
Table key
S · Form 4
Sale on the market or privately
D
Direct

Footnotes

F1
Shares were sold pursuant to a Rule 10b5-1 plan adopted on May 8, 2026.↩ 1

Signature 1

Signed
/s/ Michael V. Schrock, by Kate A. Gitter, Attorney-in- Fact
Date
2026-08-13

Company context

At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.

Current securities

Recent company filings

  1. Results of Operations and Financial ConditionOct 28, 2026
  2. Other EventsAug 24, 2026
  3. 144 filingAug 19, 2026
  4. 144 filingAug 11, 2026
  5. 10-Q filingAug 6, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.